Life Science Talent Talks

Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. 𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺: Take part in shaping this community by sharing your feedback, questions or ideas. This you can do through our community page: https://www.linkedin.com/groups/12717528/ Follow us: Nehar: https://www.linkedin.com/in/neharmortuza/ and Søren: https://www.linkedin.com/in/soren-spanner-bach/

  1. E69 #Ecosystem Builders "Denmark's Biotech Potential: Innovation Gaps, Capital Challenges & National Frameworks" with Morten Engsbye

    5 days ago

    E69 #Ecosystem Builders "Denmark's Biotech Potential: Innovation Gaps, Capital Challenges & National Frameworks" with Morten Engsbye

    In this podcast episode on turning research into societal value, host Søren Spanner Bach is joined by co-host Per Christensen of Black Swans Exist and guest Morten Engsbye, CEO of Danish BIO (Dansk Biotek) - the industry association representing over 190 pharmaceutical and industrial biotech companies in Denmark. Morten shares candid reflections on why Denmark, despite being Europe's #2 nation for per-capita life sciences publications, consistently underperforms at translating that world-class research into new companies - and what it will take to fix it. Key structural challenges discussed include the cultural gap between academic excellence and entrepreneurial ambition, the scarcity of early-stage capital as late-stage companies attract the lion's share of investment, and Denmark's 42% capital gains tax making biotech investment unattractive compared to property or neighbouring Sweden. In a world premiere, Morten also unveils Danish BIO's proposal for direct cash grants to university departments that successfully spin out companies - a mechanism designed to make innovation a leadership priority at department level, not just an individual pursuit. Morten also sounds the alarm on Denmark's GDP dependency on a small number of blockbuster drugs - life sciences now accounts for approximately 60% of all Danish GDP growth - and makes a compelling case for unlocking the country's 4.5 trillion DKK in pension fund assets, currently investing just 0.018% into venture compared to 1.9% in the US. His closing message: Denmark is a life sciences nation in every metric that matters. It just hasn't realised it yet. TIMESTAMP 00:00 Morten Engsbye and Danish BIO 01:40 The Translation Gap: World-Class Research, Not Enough Companies 03:00 Why Other Countries Are Better at Spinning Out Science 05:45 World Premiere: Danish BIO's Department-Level Spin-Out Incentive Proposal 09:20 Freedom vs Mandates: Why Incentives Beat Obligations 12:05 Genmab, Myelomatosis & What Biotech Success Really Looks Like 12:26 The GDP Time Bomb: When Patents Expire, Markets Collapse 16:30 The Capital Crisis: $2.1 Billion to Bring a Drug to Market 18:35 A Schizophrenic Capital Market: Late-Stage Flush, Early-Stage Starved 19:40 Where Should the Capital Come From? The Draghi & Letta Reports 20:15 Capital Gains Tax: 42% in Denmark vs 27% in Sweden 22:10 Pension Funds: 4.5 Trillion DKK Doing Very Little for Denmark 24:00 The 100x Gap: US vs European Pension Funds in Venture 26:00 Ferrari vs Denmark: One Fund's Investment Priorities 28:40 Forcing vs Incentivising Pension Funds: The Italian Model 30:00 Why It Should Be a Slam Dunk — Jobs, Patients, Returns 33:00 Call to Action for Academics and Department Leaders 35:00 Denmark as a Life Sciences Nation — and Why Politicians Don't See It 40:15 Brain Drain: How Danish Taxpayer-Funded Research Ends Up in Boston Quote: "We pay for the research. They build the company here. Then, because there's no capital market, they leave for Boston — pay their taxes there, create all the jobs there. And we sit back holding the bill." — Morten Engsbye Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We’d therefore love to hear your suggestions for future podcast guests, ecosystem builders, or deep tech themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Call to Action If this episode sparked your interest: Share it with someone working in science, startups, or innovation Follow the miniseries for more conversations with ecosystem builders

    42 min
  2. E68 #Ecosystem Builders "Turning Great Science into Green Impact: BRIGHT’s Mission, Model, and European Playbook” with Luuk van der Wielen

    18 Jun

    E68 #Ecosystem Builders "Turning Great Science into Green Impact: BRIGHT’s Mission, Model, and European Playbook” with Luuk van der Wielen

    In this episode, Luuk van der Wielen, Head of BRIGHT (Novo Nordisk Foundation Biotechnology Research Institute for the Green Transition), joins Søren Spanner Bach and Per Christensen from Black Swans Exist in collaboration with Life Science Talent Talks to unpack what it will take for Europe to turn biotech innovation into real, sustainable economic value. Luuk introduces BRIGHT's core mission: helping Europe reduce emissions, strengthen resource autonomy, and build a more resilient industrial base - not through isolated breakthroughs, but through the kind of system-level change that reshapes technology, supply chains, regulation, incentives, and social behavior all at once. The conversation draws on powerful historical precedents - Brazil's Proálcool biofuel program and Denmark's biogas infrastructure - to illustrate why lasting green transitions are never built on a single "silver bullet" product, but on coordinated, long-term ecosystem thinking. Luuk also shares how BRIGHT itself is evolving: moving beyond its Biosustain roots and a science-and-startup model toward more open public-private collaboration, scenario-based "reverse design" roadmaps anchored in 2050 goals, and impact-focused KPIs that go well beyond publications and patents. The episode explores BRIGHT's three strategic focus areas - sustainable materials, microbial and sustainable foods, and zero-emission agriculture - and what it means to build research infrastructure that is measured by real-world outcomes. Finally, Luuk issues a direct invitation to potential partners and makes a compelling case for deeper European collaboration and a fairer, continent-wide level playing field for biotech innovation. ⏱️ TIMESTAMP 00:00 Series Kickoff 00:36 Meet Pierre and Black Swans 01:13 Luuk’s Career Journey 04:03 What BRIGHT Does 06:28 Innovation for Green Transition 06:51 Brazil’s Biofuel Lesson 08:52 Systems Change Not Silver Bullets 10:20 BRIGHT’s Origin Story 11:56 From Startups to Partnerships 13:22 Biogas to High Value Proteins 16:04 Key Ingredients for Collaboration 17:42 Sustainable Innovation Office 18:22 Reverse Designing the Roadmap 20:28 Scenario Planning and Outreach 21:37 Tech Plus Policy and Society 22:33 Policy Targets and Autonomy 24:02 Biogas Infrastructure Strategy 26:40 Future Scenarios and Innovations 30:00 Impact Metrics in Academia 34:47 Europe Collaboration and Equity 38:03 Ecosystem Gaps and Level Playing Field 39:48 Bright Partnerships and Missions 💡 Quote: "Innovation is important in the systems change, but also the regulatory system, the financial system. You don't solve it with one super plastic that comes from BioSolutions. You have to look at the total systems change." - Luuk van der Wielen Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We’d therefore love to hear your suggestions for future podcast guests, ecosystem builders, or deep tech themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Call to Action If this episode sparked your interest: Share it with someone working in science, startups, or innovation Follow the miniseries for more conversations with ecosystem builders

    43 min
  3. E67 #Ecosystem Builders "Scaling Health Tech: Funding, Traction & Faster EU Approval" with Jesper Grønbæk

    12 Jun

    E67 #Ecosystem Builders "Scaling Health Tech: Funding, Traction & Faster EU Approval" with Jesper Grønbæk

    In this podcast episode on turning research into societal value, host Søren is joined by co-host Per Christensen of Black Swans Exist and guest Jesper Grønbæk, CEO and founder of the nonprofit Health Tech Hub Copenhagen (supported by the Danish Industry Foundation and the Novo Nordisk Foundation). Jesper shares key learnings from supporting 100+ health tech startups and scale-ups, as well as collaborating with hospitals, pharma, insurers, and a 200+ investor network - including enabling hospital “speed-dating” access in markets like Germany. Key pitfalls discussed include solving “nice-to-have” problems instead of top-priority hospital needs, failing to secure an influential key opinion leader early, starting fundraising too late while overlooking non-dilutive “soft money” grants, and lacking commercial traction due to staying overly project-focused. He emphasizes the importance of early investor relationship-building, being selective with investors, and maintaining a strong commercial focus - sometimes even launching below MDR/CE-mark requirements first. Jesper also introduces the upcoming Health Tech Pathways platform, which uses expert-trained AI to guide EU MDR medical device regulation and improve documentation quality - ultimately reducing the time and cost associated with today’s multi-year EU processes. TIMESTAMP 00:42 Meet Health Tech Hub 01:47 Ecosystem Connections 02:47 Hospital Access Speed Dating 03:50 Why Jesper Started 05:42 Healthcare Pressure Ahead 06:23 Mistake One Nice to Have 08:43 Key Opinion Leaders 10:12 Mistake Two Fundraising 10:53 Soft Money and Accelerators 12:14 Choosing Investors Wisely 14:48 Mistake Three Commercial Traction 16:42 Traction Under Regulation 18:18 Consumers Paying for Health Apps 19:14 Who Pays for Health Tech 19:56 Building Health Tech Pathways 21:27 MDR Explained and Risk Classes 22:38 Why EU Approval Takes Longer 23:50 Ideal Users and Early Strategy 24:32 Plain English Plus Compliance 26:56 AI Powered Regulatory Guidance 27:38 Cutting Time with Better Docs 28:31 Ecosystem Wishlist Reimbursement 30:33 Community Call to Collaborate 31:30 Denmark Strengths and Next Steps Quote: "Finding a co-founder is like finding a spouse — it's somebody you want to work with for a very long time in a harsh environment." — Jesper Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We’d therefore love to hear your suggestions for future podcast guests, ecosystem builders, or deep tech themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Call to Action If this episode sparked your interest: Share it with someone working in science, startups, or innovation Follow the miniseries for more conversations with ecosystem builders

    35 min
  4. E66 #Ecosystem Builders "From excellent research to real-world impact" with Jens Nielsen

    3 Jun

    E66 #Ecosystem Builders "From excellent research to real-world impact" with Jens Nielsen

    In this episode, Jens Nielsen, CEO of BioInnovation Institute, joins Søren and Per Christensen from Black Swans Exist to share how Denmark built one of the world’s leading life science startup ecosystems - and how that model is now being expanded into quantum and deep tech. Jens reflects on his journey from academic researcher and professor in engineering biology to serial entrepreneur and ecosystem builder. He discusses how his passion for translating science into real-world impact led him to found multiple companies and eventually help build BII as a launchpad for early-stage innovation. The conversation explores how ecosystems are formed, what makes academic science commercially viable, and why the combination of talent, capital, and institutional support is critical. Jens also explains why Denmark has been uniquely successful in scaling biotech startups and what lessons can be transferred to emerging fields like quantum technology. A central theme is how scientists can transition into entrepreneurship - not just through training, but through mindset shifts, feedback culture, and selecting the right people with coachability, curiosity, and resilience. The episode also dives into team dynamics, founder evolution, and why most startup challenges ultimately come down to people rather than technology. Finally, Jens shares a broader reflection on Europe’s opportunity in deep tech and why researchers must take responsibility for translating their own work into societal impact. ⏱️ TIMESTAMP 00:00 Introduction – Life Science Talent Talks Miniseries & Ecosystem Builders 01:00 Jens Nielsen’s Background - Engineering Biology, Academia & Entrepreneurship 03:00 The Birth of BioInnovation Institute (BII) 06:00 Why Denmark Became a Life Science Startup Leader 07:00 From Life Science to Quantum Ecosystems 12:00 Ingredients of a Strong Deep Tech Ecosystem 21:00 Selecting Scientific Entrepreneurs - Science + Market Fit 30:00 Rethinking Startup Education - From Lectures to Gap Analysis 32:00 Mindset of Scientific Entrepreneurs 35:00 Founder-to-CEO Evolution in Scaling Companies 39:00 Cap Tables, Equity & Managing Founder Expectations 41:00 Investor Dynamics & Founder Role Transitions 44:00 Culture, Leadership Principles & Scaling Challenges 48:00 Academic Training as Entrepreneurial Advantage 50:00 Europe vs US in Deep Tech Innovation 💡 Quote: “You cannot find a better entrepreneur to translate science than the person who actually did the science - because they know it deeply and care about making it matter.” - Jens Nielsen Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We’d therefore love to hear your suggestions for future podcast guests, ecosystem builders, or deep tech themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Call to Action If this episode sparked your interest: Share it with someone working in science, startups, or innovation Follow the miniseries for more conversations with ecosystem builders

    53 min
  5. E65 #Ecosystem Builders "Bridging Innovation: From Academia to Life Science Startups" with Søren Spanner Bach & Per Christensen

    3 Jun

    E65 #Ecosystem Builders "Bridging Innovation: From Academia to Life Science Startups" with Søren Spanner Bach & Per Christensen

    In this miniseries episode of Life Science Talent Talks, hosted by Soren in collaboration with Black Swans Exist, we explore how scientific innovation moves from universities and research hubs into real-world companies. Soren and Per Christensen (co-founder of Black Swans Exist) discuss the “bridge” between academia and industry - where great ideas are created, but not always scaled - and why talent, execution, and cross-sector collaboration are key to turning research into impactful solutions. The conversation also touches on Europe’s innovation challenges, the startup ecosystem, and the need for more entrepreneurial courage in science and academia. Timestamps 00:30 – Meet Per Christensen & his background01:00 – Purpose of the mini-series: bridging innovation and execution01:14 – What Black Swans Exist does in the ecosystem02:15 – The “bridge” between academia and real-world application02:50 – Gaps in innovation vs. execution03:00 – Untapped innovation potential within universities03:35 – Talent, funding, and enabling innovation04:00 – Why this podcast exists04:19 – Importance of ecosystem builders & shared perspectives04:30 – Inspiring entrepreneurship and showcasing role models05:15 – Breaking silos & sharing actionable learnings05:42 – What to expect from the conversations in this series06:00 – Entrepreneurial mindset in academia06:24 – Innovation and the future economy06:51 – Are we doing enough in innovation?07:00 – Europe’s strengths vs. commercialization challenges07:44 – Regulation vs. innovation discussion08:00 – Driving societal change & the need for innovators08:39 – Closing remarks Key Takeaways Innovation often exists in universities - but scaling it requires the right people and structuresTalent acquisition is a critical bottleneck in life science and deep tech startupsEurope has strong research output but struggles with commercialization and executionCross-sector collaboration can unlock faster innovationInspiration and role models can encourage more people to start companiesBridging academia and industry is essential for future economic growth Notable Quotes “If we inspire just one person to start a company, it’s a success.” “We need innovators and brave people willing to take risks.” Call to Action If this episode sparked your interest: Share it with someone working in science, startups, or innovation Follow the miniseries for more conversations with ecosystem builders

    9 min
  6. E64 #StartupStory "Building Biotech from Scratch: The Immunordic Journey" with Emil Arvedsen & Jannik Faliu

    24 Feb

    E64 #StartupStory "Building Biotech from Scratch: The Immunordic Journey" with Emil Arvedsen & Jannik Faliu

    In this episode, Emil and Jannik, co-founders of Immunordic share their journey of building a startup in the biotech industry. They discuss the challenges they faced while developing a technology platform for identifying protein binders using limited resources.  The conversation covers their initial focus on building synthetic libraries and wet lab methods, the pivot to an AI and machine learning-based approach, and the lessons learned from both successes and setbacks. Key insights include the importance of networking, how to build a lab on a tight budget, and the value of persistence and passion in driving a startup forward. They also outline their current focus and future directions, aiming to provide accessible scientific tools for diagnostics, therapeutics, and academic research. 00:40 Founders' Backgrounds 02:29 Immunordic's Mission and Services 03:32 The Origin Story 06:08 Early Challenges and Lessons 11:17 Building the Lab 18:43 Funding and Resources 20:52 Understanding Through Teaching 21:55 Enrolling and Guiding New Lab Members 22:35 Identifying Student Drives and Aligning Projects 23:40 Challenges and Successes with Student Projects 24:39 The Pivot to In Silico Prediction 25:19 Building Synthetic Libraries and Bio Panning 26:08 Challenges with Wet Lab Services 27:50 Transitioning to Scalable Solutions 28:37 Adopting In Silico Methods 30:40 Client and Market Reactions to the Pivot 39:10 Future Plans and Collaborations Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Join Our Life Science Talent Ecosystem We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

    41 min
  7. E63 #Leadership “Future-Ready Leadership In The Era Of AI” with Marcelina Dutkiewicz

    04/12/2025

    E63 #Leadership “Future-Ready Leadership In The Era Of AI” with Marcelina Dutkiewicz

    In this conversation, Marcelina outlines a practical roadmap for AI transformation within life sciences organizations, emphasizing that real progress begins with leadership alignment and people-centric change management. She explains that senior leaders must first gain a foundational understanding of AI—ideally becoming super users—to communicate vision, reduce uncertainty, and guide their teams effectively. People leaders then play a crucial role in translating strategy into day-to-day meaning for employees, influencing priorities, workflows, and professional development. Marcelina also highlights the importance of governance, data readiness, and collaboration between C-suite leaders and boards, many of whom acknowledge the need for AI upskilling. She stresses that successful AI adoption requires tailored training, not generic programs, referencing research that shows customized learning dramatically increases the number of super users and hours saved weekly. Throughout the discussion, she shares insights from her book It Starts With Vision, including interviews with senior leaders across pharma, data science, IT security, and organizational transformation. She encourages leaders to begin with curiosity, assess their organization’s current maturity, and use surveys and strategic sparring to design transformations that avoid wasted investment and maximize impact. Key Topics Covered: 00:32:38 Why messaging from senior leadership and people leaders matters most in AI transformation. 00:34:00 Building the AI roadmap: upskilling senior leaders, creating super users, and enabling informed conversations. 00:35:32 The role of boards in guiding AI strategy and the increasing need for board-level AI literacy. 00:36:53 Training leaders, preparing for employee concerns, and aligning grassroots initiatives with strategy. 00:38:32 Why organizations start at different points in their AI journey and how to avoid siloed efforts. 00:40:15 Introduction to Marcelina’s book and why AI must be treated as a human-centered transformation. 00:42:21 Interviews inside the book: data science, pharma innovation, IT security, and change leadership. 00:46:02 Where to buy the book and why it’s a limited-edition release. 00:47:31 Why generic AI guidance fails—and how job-specific training changes adoption outcomes. 00:49:20 How Marcelina uses surveys to diagnose readiness and provide targeted leadership support. 00:51:29 Final call to action: read the book, take the survey, and seek tailored support. Notable Quotes: “This is a people-centric transformation—employees deserve to be led well through it.” “Senior leaders don’t need to be specialists, but they must understand AI well enough to speak its language.” “Tailored, job-specific training creates super users—generic AI training does not.” “We need governance that can say yes and no to grassroots AI initiatives with confidence.” “Once employees understand AI, they become drivers of process optimization instead of blockers.” CTA: Download the AI readiness survey to assess your AI maturity. Follow Marcelina on LinkedIn for weekly insights on AI, leadership, and transformation. Get the limited-edition book It Starts With Vision before the next print run out. Exclusive treat: Apply TALENT10 at checkout for 10% off!

    53 min
  8. E62 #StartupStory “AI-Driven Antibody Design: A Journey from Academia to Industry” with Rahmad Akbar Senior data scientist at Novo Nordisk

    06/08/2025

    E62 #StartupStory “AI-Driven Antibody Design: A Journey from Academia to Industry” with Rahmad Akbar Senior data scientist at Novo Nordisk

    In this episode of Life Science Talent Talks, host Nehar Mortuza sits down with Rahmad Akbar, Senior Data Scientist in Antibody Design at Novo Nordisk. Rahmad shares his remarkable journey from his roots in Indonesia to his pivotal role at the forefront of machine learning-driven protein engineering. Together, they explore how AI is revolutionising antibody design — from the technical advances and current challenges to the growing role of generative models in creating next-generation therapeutics. Rahmad offers insights into how these technologies are accelerating drug discovery, improving patient outcomes, and shaping the future of healthcare. He also speaks candidly about his transition from academia to industry, the personal motivations that fuel his work, and why collaboration and innovation are more essential than ever in the life sciences. Whether you're passionate about biotech, data science, or career development, this episode is packed with valuable perspectives you won't want to miss. Timestamp and Show notes: 00:38 Meet Our Special Guest: Rahmad Akbar 02:19 Rahmad's Journey: From Indonesia to Novo Nordisk 03:35 The Role of Coding in Biotechnology 04:45 Antibody Design: Challenges and Innovations 06:48 Generative AI in Drug Design 10:04 Future Trends and Democratizing AI 19:00 Personal Motivations and Career Reflections 24:31 Transitioning from Academia to Industry 29:47 Final Thoughts and Takeaways Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes. Join Our Life Science Talent Ecosystem We want to build a community to inspire life science professionals and leaders through talent talks and organised events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

    32 min
5
out of 5
13 Ratings

About

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. 𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺: Take part in shaping this community by sharing your feedback, questions or ideas. This you can do through our community page: https://www.linkedin.com/groups/12717528/ Follow us: Nehar: https://www.linkedin.com/in/neharmortuza/ and Søren: https://www.linkedin.com/in/soren-spanner-bach/

You Might Also Like